Which pharmaceutical product became the first to receive FDA approval based partially on data collected through a digital health platform rather than traditional clinical trials alone?

The medical industry has been revolutionized by digital health technologies that are changing how clinical trials are conducted and how drugs are approved. In recent years, regulatory bodies have begun accepting real-world data from digital platforms as supporting evidence for drug approvals. This represents a significant shift in the pharmaceutical product launch landscape. Test your knowledge about this landmark change in medical product approval processes!

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Rybelsus (semaglutide) for type 2 diabetes, using continuous glucose monitoring data
Medtronic's Guardian Connect CGM System, using Apple HealthKit integration data
Pfizer's Paxlovid for COVID-19, using smartphone-reported symptom tracking
Flatiron Health's real-world evidence supporting Roche's Alecensa (alectinib) for lung cancer